BackAcasti Pharma Overview

Acasti Pharma Total Liabilities

Track Acasti Pharma's total liabilities ($2.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.76M
48.76% YoYΔ $-2.63M vs prior year quarter

Peer average / median

Loading

Acasti Pharma Total Liabilities History

Loading

Acasti Pharma vs. peers: Total Liabilities Comparison

Loading

Acasti Pharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acasti Pharma (ACST) FAQ

The latest total liabilities for ACST is $2.8M as of March 2026. That compares with $5.4M in the prior-year period — down 48.8% year over year. Investors often review this figure alongside Acasti Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACST's total liabilities moved from $5.4M to $2.8M — a 48.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acasti Pharma's operating scale or balance-sheet position.

A total liabilities figure of $2.8M for ACST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACST's total liabilities ($2.8M), review year-over-year change from $5.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Acasti Pharma's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.